GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » EV-to-FCF

AIM Vaccine Co (HKSE:06660) EV-to-FCF : -19.77 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AIM Vaccine Co's Enterprise Value is HK$10,101 Mil. AIM Vaccine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-511 Mil. Therefore, AIM Vaccine Co's EV-to-FCF for today is -19.77.

The historical rank and industry rank for AIM Vaccine Co's EV-to-FCF or its related term are showing as below:

HKSE:06660' s EV-to-FCF Range Over the Past 10 Years
Min: -61.47   Med: -23.95   Max: -9.03
Current: -19.77

During the past 5 years, the highest EV-to-FCF of AIM Vaccine Co was -9.03. The lowest was -61.47. And the median was -23.95.

HKSE:06660's EV-to-FCF is ranked worse than
100% of 369 companies
in the Biotechnology industry
Industry Median: 8.9 vs HKSE:06660: -19.77

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), AIM Vaccine Co's stock price is HK$7.43. AIM Vaccine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-1.171. Therefore, AIM Vaccine Co's PE Ratio for today is At Loss.


AIM Vaccine Co EV-to-FCF Historical Data

The historical data trend for AIM Vaccine Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co EV-to-FCF Chart

AIM Vaccine Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - -28.25 -21.40

AIM Vaccine Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - -28.25 - -21.40

Competitive Comparison of AIM Vaccine Co's EV-to-FCF

For the Biotechnology subindustry, AIM Vaccine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AIM Vaccine Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AIM Vaccine Co's EV-to-FCF falls into.



AIM Vaccine Co EV-to-FCF Calculation

AIM Vaccine Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10101.315/-510.953
=-19.77

AIM Vaccine Co's current Enterprise Value is HK$10,101 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-511 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AIM Vaccine Co  (HKSE:06660) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AIM Vaccine Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.43/-1.171
=At Loss

AIM Vaccine Co's share price for today is HK$7.43.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-1.171.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


AIM Vaccine Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AIM Vaccine Co (HKSE:06660) Business Description

Traded in Other Exchanges
N/A
Address
91 Jianguo Road, 25th Floor, Building A, Chaoyang, Beijing, CHN
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development, manufacturing and commercialization. The products available for sale mainly include Recombinant HBV vaccine, Human rabies vaccine, HFRS Vaccine, hepatitis A vaccine (human diploid cell), Group A, C, Y and W135 MPSV, mumps vaccine, freeze-dried human rabies vaccine (Vero cell) and ACYW135 meningococcal polysaccharide vaccine. Geographically, the company generates all of its revenues in the PRC.
Executives
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si 2101 Beneficial owner
Yong Zhou Qing Teng Mao Yi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Lihua 2201 Interest of corporation controlled by you
Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo 2201 Interest of corporation controlled by you
Zhu Hai Tong Dao Ming Tian Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Mei Hua Sheng Wu Ke Ji Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
La Sa Mei Hua Sheng Wu Tou Zi Kong Gu You Xian Gong Si 2101 Beneficial owner
Xi Zang Dong Fang Zhi Hui Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shen Yang Qian Qian Qi Ye Guan Li Zi Xun You Xian Gong Si 2101 Beneficial owner

AIM Vaccine Co (HKSE:06660) Headlines

No Headlines